Participant Use of Data Clause Samples
The "Participant Use of Data" clause defines how participants in an agreement are permitted to access, use, and share data collected or generated during the course of their involvement. Typically, this clause outlines the types of data covered, any restrictions on its use (such as prohibiting commercial exploitation or limiting use to research purposes), and may specify requirements for data security or confidentiality. Its core function is to ensure that all parties understand their rights and obligations regarding data, thereby protecting sensitive information and preventing misuse or unauthorized disclosure.
Participant Use of Data. 5.1 All use of Data submitted to DNS-OARC will take place on DNS-OARC computers. DNS-OARC will provide powerful server computers with high-speed access to the file servers and databases holding the Data to which Participant is permitted access. Participant will copy its data-analysis software to DNS-OARC computers and run that software there. Results of such analysis are considered Derivative Data, and when exported back to Participant’s computers are not permitted to contain Raw Data nor can any exported results contain identifying information.
5.2 Participant shall not use or circulate Confidential Data within its own organization or its affiliates (i.e. entities controlled by or under common control with Participant) other than as strictly necessary on a need-to-know basis, and then with appropriate written confidentiality agreements. In no event shall Participant cause, permit or enable any third party to have access to or use Confidential Data in any manner whatsoever without the prior written consent of both the disclosing party and the Board of Directors and the execution by such third party of an appropriate written confidentiality agreement. In no event shall Participant (or anyone to whom it discloses Confidential Data) package or repackage any Confidential Data into a commercial product or service.
5.3 Participants are encouraged to publish the results of their analysis of the Data at DNS-OARC workshops and other public fora. All publication of Derivative Data must include acknowledgment of DNS-OARC as the source of the Data. Prior to publication, Participant must seek and obtain written permission from DNS-OARC for such publication, to allow DNS- OARC to verify that all terms of this Agreement are being adhered to.
Participant Use of Data. When accessing or using Patient Data pursuant to the Agreement, Participant and Authorized Users may access and/or use Patient Data to perform any activities Participant is allowed to perform under the Agreement (including the Policies).
Participant Use of Data. When accessing or using Patient Data pursuant to the Agreement, Participant and Authorized Users may access and/or use Patient Data to perform any activities Participant is allowed to perform under the Agreement (including the Policies). Participant and Authorized Users may also access Patient Data when Participant is acting as a Business Associate of another Covered Entity, provided that: all documentation of that relationship is completed to MX’s satisfaction: Participant complies with that documentation; and the arrangement complies with Law. Notwithstanding any other provision of the Agreement, if Participant or an Authorized User accesses any Patient Data that it is not permitted to access under the Agreement at the time of that access, then Participant: (i) will be in breach of the Agreement, (ii) will not have or obtain any right to that Patient Data, and (iii) must immediately return or destroy that Patient Data.
Participant Use of Data. 5.1 All use of Data submitted to DNS-OARC will take place on DNS-OARC computers. DNS-OARC will provide powerful server computers with high-speed access to the file servers and databases holding the Data to which Participant is permitted access. Participant will copy its data-analysis software to DNS-OARC computers and run that software there. Results of such analysis are considered Derivative Data, and when exported back to Participant’s computers are not permitted to contain Raw Data nor can any exported results contain identifying information.
5.2 Participant shall not use or circulate Confidential Data within its own organization or its affiliates (i.e., entities controlled by or under common control with Participant) other than as strictly necessary on a need-to-know basis, and then with appropriate written confidentiality agreements. In no event shall Participant cause, permit or enable any third party to have access to or use Confidential Data in any manner whatsoever without the prior written consent of both the disclosing party and the Board of Directors and the execution by such third party of an appropriate written confidentiality agreement. In no event shall Participant (or anyone to whom it discloses Confidential Data) package or repackage any Confidential Data into a commercial product or service.
Participant Use of Data. When accessing or using Patient Data pursuant to the Agreement, Participant and Authorized Users may access and/or use Patient Data to perform any activities Participant is allowed to perform under the Agreement (including the Policies). Notwithstanding any other provision of the Agreement, if Participant or an Authorized User accesses any Patient Data that it is not permitted to access under the Agreement at the time of that access, then Participant: (i) will be in breach of the Agreement, (ii) will not have or obtain any right to that Patient Data, and (iii) must immediately return or destroy that Patient Data.